To the Editor:Coronavirus disease 2019(COVID-19)has become a worldwide public health emergency,threatening public health and global stability[1].The development of a safe and effective vaccine is urgently needed to co...To the Editor:Coronavirus disease 2019(COVID-19)has become a worldwide public health emergency,threatening public health and global stability[1].The development of a safe and effective vaccine is urgently needed to control the pandemic.Generally,nanoparticle(NP)vaccines can generate a more potent immune response than mRNA vaccines[2].展开更多
基金This work was supported by the National Special Research Program of China for Important Infectious Diseases(2017ZX10202102 and 2018ZX10302103)the Special 2019-nCoV Project of the National Key Research and Development Program of China(2020YFC0841400)+4 种基金the First Panel of 2021 Emergency Key Program of Guangzhou Laboratory(EKPG21-24)the Special 2019-nCoV Program of the Natural Science Foundation of China(NSFC)(82041002)the Special Research and Development Program of Guangzhou(202008070010)the Important Key Program of NSFC(81730060)the Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou(201803040002)to H.Z.
文摘To the Editor:Coronavirus disease 2019(COVID-19)has become a worldwide public health emergency,threatening public health and global stability[1].The development of a safe and effective vaccine is urgently needed to control the pandemic.Generally,nanoparticle(NP)vaccines can generate a more potent immune response than mRNA vaccines[2].
